スペイン、マドリード    2024年4月21日~24日

企画:

主催:

プログラム

2024年WFH世界会議
[email protected]

企画:
世界血友病連盟

主催:
Federación Española de Hemofilia

2024年WFH世界会議では、医学および出血性疾患患者(PWBD)トラックと、看護学、歯科学、実験科学、社会心理学、筋骨格学(MSK)および出血性疾患を抱える女性および女児(WGBD)の6つの専門的能力開発トラックにわたる継続教育セッション(90分間)をご用意しています。全員参加のセッションおよび各セッションでは世界クラスの講演者が登壇することや、対話形式のセッション、ワークショップ、パネルディスカッション、革新的な業界シンポジウムが実施されることもこの会議の特徴です。

CME CREDITS

The WFH 2024 World Congress has been accredited with 32 credits by the European Board for Accreditation in Hematology (EBAH), an accreditation body supported and endorsed by the European Hematology Association (EHA).

Participants have until 2024年5月15日, 23:59 EST to create an EBAH account and complete the daily surveys in order to obtain CME credits. Participants will be able to print their EBAH-CME certificate via the EBAH-CME system after 2024年5月31日.

Daily questionnaires

Please fill out a form for each day you wish to claim credits for.
Click here to access the questionnaire.

Participants should only claim credits for the time actually spent at the World Congress.

EBAH account

To find your EBAH-CME number, log in to your EBAH account (login) or create an EBAH CME account if you do not already have one (create account).

  1. Creating an EBAH CME account or logging in is simple and free.
  2. Please add your EBAH CME account number in the questionnaires

Within the EBAH-CME system, you will be able to:

  • Print your EBAH-CME certificates.
  • Review and manage your personal account.
  • Search for accredited events based on the European Hematology Curriculum.

For further assistance with your EBAH account please contact:

EBAH Office
Koninginnegracht 12b, 2514 AA – The Hague, The Netherlands
Phone: +31 (0)70 3020 099
Email: [email protected]

  • 1 hour of CME-CPD activity = 1 EBAH CME-CPD credit point
  • Maximum of 8.0 EBAH CME credit points per Congress day

Participants will be asked to complete a questionnaire for each day they are claiming credits, in order to confirm their participation in our scientific program.

SYMPOSIA SCHEDULE

Explore our dynamic symposia schedule, offering a diverse array of engaging topics. All symposia will be held in Exhibit Hall 9.

12:45-13:45

ROOM 1: Takeda

Unleashing the management of patients with hemophilia A with inhibitors – from expert opinion to clinical decision


12:45-13:45

ROOM 2: WFH session – supported by CSL Behring

Living the gene therapy treatment journey (WFH)


12:45-13:45

ROOM 3: Sobi Sanofi

Reaching new heights in hemophilia A: the impact of higher factor levels


18:30-19:30

ROOM 1: Pfizer

New horizons: The value of continued innovation in hemophilia


18:30-19:30

ROOM 2: Hoffmann-La Roche

Dreaming the future – how can we achieve optimal care and make health equity a reality for all people living with hemophilia A?


18:30-19:30

ROOM 3: Octapharma

Must-have Insights on prophylaxis in hemophilia A and von Willebrand disease

12:45-13:45

ROOM 1: Biomarin

Gene therapy in hemophilia: from decision to dosing


12:45-13:45

ROOM 2: CSL Behring

Optimizing the patient journey in von Willebrand disease: experiences and learnings as the navigator


12:45-13:45

ROOM 3: Sanofi

Redefining hemophilia: finding hemostatic balance within the evolving treatment landscape

*

The World Federation of Hemophilia does not endorse particular treatment products or manufacturers; any reference to a product name is not an endorsement by the WFH. The WFH is not a regulatory agency and cannot make recommendations relating to safety of manufacturing of specific treatment products. Some sessions may be accessible to healthcare professionals only.

NETWORKING OPPORTUNITIES

この国際的な集まりを通じて知識と喜びを融合させるため、あなたもぜひ仲間になってください。WFHのオープニングセレモニーが、マドリードの豊かな文化が織り込まれた魅惑的な背景の中で人脈を広げ、緊張を解き、素晴らしい時間を過ごす好機となることをお約束します。2024年WFH世界会議を学びの場とするのはもちろん、ひらめきとつながりの源にしていきましょう!

Please note that in adherence to Madrid regulations, cultural events and entertainment at social gatherings organized by the host (WFH) are not permitted during the WFH 2024 World Congress. We appreciate your understanding and eagerly anticipate providing you with a seamless and enriching, knowledge-focused experience at this year’s Congress. Your participation is highly valued, and we look forward to making this event as informative and enjoyable as possible.

PRESENTATION THEATRE

Stop by the presentation theatre in Exhibit Hall 9 for a number of exciting sessions.

ABSTRACTS AND POSTERS

View the 2024 ePoster gallery now.

The WFH would like to thank our expert Abstract Review Committee for the time they took to review the 2024 abstract submissions. Their contribution in the impartial review process has allowed the WFH to maintain a high level of quality for the WFH 2024 World Congress program.

There will be as many as 45 free paper oral presentations and 75 moderated poster presentations, in addition to the 300+ posters displayed in our in-person and virtual poster galleries. For more information on our free paper and moderated poster sessions, please visit our full program.

Poster and presentation guidelines

Presenting authors should download and carefully read the following guidelines prior to preparing and submitting their poster and/or presentation.

Free paper presentation

Click on the button below to access the free paper presentation guidelines.

Moderated poster presentation

Click on the button below to access the moderated poster presentation guidelines.

Poster submission guidelines

Click on the button below to access the poster submission guidelines.

演題登録方法

登録される前に、必ず演題登録ガイドラインをよくお読みください。

演題登録方法

ステップ1: プロフィールを作成してログインし、演題スコアカード(Abstract Scorecard)にアクセスします。

ステップ2: 演題登録に必要な手順をすべて行います。

ステップ3: すべて完了したら、登録する(submit)をクリックします。

登録した演題を編集する

登録期限の2024年02月14日までは、登録した演題を編集することができます。

ステップ1: 演題を編集するには、演題スコアカード(Abstract Scorecard)サイトにログインしてご自身の演題にアクセスします。ここで、すでに入力済みのタスクにアクセスし、更新することによって演題を編集することができます。

重要な注意事項:

演題は、このオンラインシステム以外では登録できません。 郵送や電子メールで提出されたものは審査対象外となります。
適切に登録されたもののみ審査対象となります。不備がある場合は自動的に不受理となります。

2024年WFH世界会議の演題査読委員会は、幅広い専門分野と科学的手法を持つ者から構成される優れた専門家集団です。

Prem Roop Alva

Jan Astermark

Cindy Bailey

Branislav Bajkin

Marlène Beijlevelt

Erik Berntorp

Greig Blamey

Megan Brown

Tyler Buckner

Patricia Cabré

Manuel Carcao

Alessandro Casini

Giancarlo Castaman

Nathan Connell

Elvira Correa

Susan Cutter

Emmanuel Favaloro

Antonio Gavrilovski

Gaby Golan

Emna Gouider

Cesar Haddad

Cathy Harrison

Cedric Hermans

Shannon Jackson

Paula James

Christine Kempton

Kate Khair

Steve Kitchen

Christoph Königs

Barbara Konkle

Roshni Kulkarni

Riitta Lassila

Michelle Lavin

David Lillicrap

Johnny Mahlangu

Mike Makris

Tadashi Matsushita

Paul McLaughlin

Wolfgang Miesbach

Richa Mohan

Lochana Nanayakkara

Margareth Ozelo

David Page

Gianluigi Pasta

Glenn Pierce

Steve Pipe

Debra Pollard

Margaret Rand

Hortensia de la Corte Rodriguez

Dawn Rotellini

Thomas Sannié

Veena Selvaratnam

Roger Schutgens

Midori Shima

Robert Sidonio

Mauricio Silva

Mark Skinner

Penni Jo Smith

Alok Srivastava

Jeff Stonebraker

Sophie Susen

Merel Timmer

Graeme Ting

Pierre Toulon

Nanda Uitslager

Angela Weyand

Sarah Whitaker

Abstract Public Release (Embargo) Dates and Times

Late-breaking abstracts (LBAs) will be publicly released throughout the WFH 2024 World Congress. The complete embargo dates and public release schedule for LBAs is detailed below.

All other abstracts, including those submitted during the late-breaking submission time period but not selected as late-breaking abstracts, will be publicly released at 9:00 a.m. CEST on 2024年4月21日, and available online.

ABSTRACTS
Abstracts published in the Haemophilia journal Embargo will lift
9:00 a.m. CEST on 2024年4月21日
LATE-BREAKING ABSTRACTS
Free paper presentation date Embargo will lift
Monday, April 22 9:00 a.m. CEST on 2024年4月22日
Tuesday, April 23 9:00 a.m. CEST on 2024年4月23日
Wednesday, April 24 9:00 a.m. CEST on 2024年4月24日

この会議は、2024年に開催される出血性疾患に関する国際イベントでは最も包括的なものとなります。発表者は世界中のトップクラスの専門家や研究者と成果物を共有することができます。

選出された演題は以下の対象となります。

バーチャルポスターギャラリーでの表示–オンラインで60日間閲覧可能
Haemophilia誌(WFHの公式刊行物)への掲載
一般演題セッションでの口頭発表
座長の進行によるポスターセッションにおけるライトニングラウンド発表(Lightning round presentation:短い時間制限が設けられたプレゼンテーション)
ポスターでのネットワーキングイベントおよび休憩時間中の印刷したポスターを使用した発表
口頭発表の最優秀者に贈られるChristine Lee Young Researcher Award(Christine Lee若手研究者賞)
ポスター発表の最優秀者に贈られるChristine Lee Young Researcher Award(Christine Lee若手研究者賞)– 2024年初!
優れた演題に贈られるトラベル賞 – 2024年初!

マドリードでお会いできることを楽しみにしています!

重要な日付
演題募集開始日 2023年9月15日
演題登録期限 2023年11月30日午後11:59(米国東部時間)
著者への通知 2023年12月22日
発表者の登録期限 2024年1月31日
LATE-BREAKING ABSTRACT(演題募集締め切り以降に進展があった研究)
Late-breaking abstract募集開始日 2024年1月17日
Late-breaking abstract登録期限 2024年2月14日午後11:59(米国東部時間)
著者への通知 2024年3月15日
発表者の登録期限 2024年3月31日

演題をオンラインで提出する前に、以下のガイドラインをダウンロードしてよくお読みください。

ず演題登録ガイドライン

Late-breaking abstract(LBA)の登録期間は、20241172024214です。

Late-breaking abstractは、日常診療に変化をもたらす最新の進歩について記述してあり、診療を変える新しい研究に光を当てているものとします。選考プロセスでは、独創的でほかに例を見ないデータが使用され、世界会議で発表されたことがない演題を優遇します。いずれの場合も、通常の演題登録期限以降に十分な結果を得られたものを対象とします。

Abstract Public Release (Embargo) Dates and Times

Late-breaking abstracts (LBAs) will be publicly released throughout the WFH 2024 World Congress. The complete embargo dates and public release schedule for LBAs is detailed below.

All other abstracts, including those submitted during the late-breaking submission time period but not selected as late-breaking abstracts, will be publicly released at 9:00 a.m. CEST on 2024年4月21日, and available online.

ABSTRACTS
Abstracts published in the Haemophilia journal Embargo will lift
9:00 a.m. CEST on 2024年4月21日
LATE-BREAKING ABSTRACTS
Free paper presentation date Embargo will lift
Monday, April 22 9:00 a.m. CEST on 2024年4月22日
Tuesday, April 23 9:00 a.m. CEST on 2024年4月23日
Wednesday, April 24 9:00 a.m. CEST on 2024年4月24日

2024年WFH世界会議の演題査読委員会は、幅広い専門分野と科学的手法を持つ者から構成される優れた専門家集団です。

Poster networking event

When: Monday, April 22 – 19:30-20:30
Where: Poster gallery within the exhibit hall


Learn more about the work and research showcased in our poster gallery, from the authors themselves! Join us for an evening of sharing information, fostering connections, sparking conversations, and inspiring collaboration within the bleeding disorders community.

演題登録

さあ、今すぐにあなたの成果物を登録して、数多くの一流の専門家に加わり出血性疾患患者の治療やケアにおける最新の進歩について話し合いましょう。

ご不明な点がありましたら、[email protected] へご連絡ください。

HAEMOPHILIA SUPPLEMENTS

WFH 2024 State of the Art Book

This peer reviewed supplement reflects the best clinical practice advice and expert opinion within the various subspecialties of bleeding disorders and related fields that will be presented in the scientific program of the WFH 2024 World Congress.


WFH 2024 Book of Abstracts

Plan your calendar for free paper sessions, moderated poster presentations, and a comprehensive poster gallery, all showcasing the research and work presented on the abstracts of the WFH 2024 World Congress.

演題に与えられる賞

Christine Lee Young Researcher Award (Christine Lee若手研究者賞)

Christine Lee Young Researcher Award(旧名称はChristine Lee Haemophilia Journal Award[Christine Lee Haemophilia誌賞])は、世界血友病連盟(WFH)とWiley社が2012年に創設した賞で、血友病やその他関連する出血性疾患と関係のある学問分野において、高評価を得た登録演題の筆頭著者および発表者である最も優秀な若手研究者(大学院生や博士研究員)として認められた者に贈られます。

Congratulations to our 2024 winners:

Best oral presentation

Geneviève McCluskey
France
Fitusiran displays efficient pro-hemostatic activity in a mouse model of inducible factor X-deficiency

Best poster presentation

Rodrigo Núñez Cortés
Chile
Effects of resistance training on muscle strength in adults with haemophilia: a systematic review and meta-analysis


口頭発表最優秀賞

賞金3,000米ドルと、Haemophilia誌のオンライン個人購読3年間が贈られます。


ポスター発表最優秀賞

賞金1,000米ドルと、Haemophilia誌のオンライン個人購読3年間が贈られます。

選考対象者

選考委員会(Haemophilia誌編集者と編集委員会のWFH代表者など)が、2024年WFH世界会議で最優秀演題を選出します。受賞者は各賞につき1名とします。

演題登録時に40歳未満の若手研究者であること。著者が複数の場合、筆頭著者および発表者は演題登録時に40歳未満である必要があります。

優れた演題に贈られるトラベル賞

WFHは、2024年WFH世界会議に登録された演題のうち高評価を得た5演題に対し、それぞれ1,000米ドルの補助金を提供します。

Congratulations to our 2024 travel award winners:
Bianca Da Silva, Australia
Glenda Feldberg, Brazil
Laura McDonald, Canada
Maria Santaella, United States
Yu Yang, China

ABSTRACTS FAQ

Q
How long should my abstract be?
A

Your abstract should be no longer than 350 words. This does not include the author’s details, titles, tables, and graphs.

Q
Can I include tables/graphs in my abstract?
A

A maximum of two tables and/or graphs can be included in an abstract. Please make sure to add headings to each of the tables and/or graphs, and reference them within the abstract. Please do not include the author list on the figure/table you are uploading, as we operate by blind review.

Q
How many abstracts can I submit?
A

There is no limit on the number of abstracts a single author can submit.

Q
How many abstracts can I present?
A

Each presenting author may present a maximum of two abstracts at Congress. Should an author have more than two abstracts accepted, a co-author must be named as the presenting author for the third or more abstracts.

Q
Can I submit my abstract by email?
A

No. Abstracts should only be submitted through the online submission system. Abstracts sent via email will not be accepted.

Q
Can I submit an abstract in a language other than English?
A

No. Abstracts will only be accepted in written English. Abstracts submitted in any language other than English will be automatically rejected.

Q
How many authors can be listed for each submission?
A

A maximum of 20 authors is permitted on each abstract.

Q
Can I edit/make changes to my abstract?
A

Revisions can be made until the late-breaking abstract submission deadline: 2024年2月14日 at 11:59pm ET. To ensure the integrity of the review process, no revisions will be allowed after the late-breaking abstract submission deadline.

Q
Can I submit a trial-in-progress abstract?
A

Yes. The WFH is accepting trials-in-progress abstracts. Please consult the abstract submission guidelines for details.

Q
Can an administrator/third party submit an abstract on behalf of the authors?
A

Yes. However, note that if the abstract is accepted, all subsequent notifications and correspondence will be addressed to the presenting author.

Q
When will I know if my abstract has been accepted?
A

You will be notified if your abstract has been accepted no later than 2023年12月22日. You will be notified if your late-breaking abstract has been accepted no later than 2024年3月15日.

Q
Do I need to register to attend the World Congress?
A

Yes. All regular abstract presenting authors must register to attend the WFH 2024 World Congress by 2024年1月31日. All LBA presenting authors must register to attend the WFH World Congress by 2024年3月31日. After this date, presenting authors who have not registered and paid their registration fees will be excluded from the program as well as from the Haemophilia journal publication. Registration fees will not be waived.

Q
Can I present virtually?
A

No. The 2024 World Congress will take place in-person only. Presenting authors will therefore be required to be onsite in Madrid, Spain.

Q
When will my accepted abstract be published?
A

Abstracts selected for publication will be made available in the online Haemophilia journal publication by 2024年4月21日. The publication will be available on the Wiley website, the WFH 2024 World Congress website, and the Congress mobile app. Late-breaking abstracts selected for publication will be made available after Congress. More information to come.

Q
Will the WFH be accepting late-breaking abstracts?
A

Yes. The call for late-breaking abstracts will open on 2024年1月17日 and will close on 2024年2月14日.

Additional questions? Please contact us at [email protected].

Thank you for subscribing!

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.